预防老年患者慢性硬膜下血肿术后复发的临床体会

Clinical Experience of Preventing the Recurrence of Senile Patients after the Chronic Subdural Hematoma Surgery

目的探讨慢性硬膜下血肿手术治疗后的复发因素及相应对策。方法方便收集2013年1月—2017年4月该院手术治疗的70例老年慢性硬膜下血肿患者,随机分为观察组和对照组,观察组35例术后口服阿托伐他汀钙片20mg,po,qd。对照组35例未服用阿托伐他汀,结合临床及相关文献对其复发情况进行分析。结果观察组未发现复发,对照组术后复发6例,复发率为17.1%,实验组与对照组经Fisher检验比较差异有统计学意义(P=0.025<0.05),对照组的复发率高于实验组。结论阿托伐他汀在预防慢性硬膜下血肿术后复发中具有肯定效果。

Objective To explore the recurrence factors and corresponding strategies of preventing the recurrence of senile patients after the chronic subdural hematoma surgery. Methods 70 cases of senile patients with chronic subdural hematoma treated in our hospital from January 2013 to April 2017 were convenient selected and randomly divided into two groups with 35 cases in each, the observation group took the atorvastatin calcium tablets of 20 mg,po,qd orally, while the control group did not take the atorvastatin calcium tablets, and the recurrence situation was analyzed according to the clinical related literatures. Results No one reoccurred in the observation group, and 6 cases reoccurred in the control group after surgery, and the recurrence rate was 17.1%, and the difference between the two groups after the Fisher test was obvious（P=0.0250.05）,and the recurrence rate in the control group was higher than that in the experimental group. Conclusion The effect of preventing the recurrence of senile patients after the chronic subdural hematoma surgery is positive.